CARLSBAD, Calif. – December 1, 2022 – ( Newswire.com )
Virgo Surgical Video Solutions (“Virgo”) today announced that the company has received an investment from the American Gastroenterology Association (“AGA”), AGA’s new venture capital fund, GI Opportunity Fund 1.
“While AGA has long championed innovators who share our goal of improving digestive health care, we have redoubled this commitment by establishing the GI Innovation Fund. The fund’s first investment – Virgo – exemplifies our pursuit of improved clinical care,” says Lawrence Kosinski , MD, AGAF, AGA Governing Board Advisor for Development and Growth. “Through our venture fund, gastroenterologists can join AGA to invest in fast-growing, early-stage companies that are transforming care for patients with digestive disease.”
Virgo provides gastroenterologists, clinical trial sponsors and trial investigators with AI-fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with inflammatory bowel disease clinical trials.
“Virgo would not be where it is today without the support of the AGA, dating back to our initial presentation at the AGA Tech Summit’s Shark Tank competition in 2018,” said Matt Schwartz, co-founder and CEO of Virgo. “Virgo is proud to have the support of the AGA, and this investment will help accelerate Virgo’s mission to improve patient outcomes and clinical workflows by developing automation and AI tools for endoscopy.”
“As its partner in the GI Opportunity Fund, Varia shares the AGA’s passion for supporting exciting innovations that benefit the GI field. Our partnership is designed, however, to do more than that. We firmly believe that this fund will also can create an unusual opportunity. for members interested in venture capital investing at an unusually low entry point. We believe we can accomplish these multiple goals by making investments in companies like Virgo Surgical Video Solutions. Its video capture, management, and artificial intelligence analytics technology platform has a large promise to advance the field of endoscopic medicine,” said Scott Friedman, co-founder and managing partner of Varia Ventures.
More information about AGA’s GI Opportunity Fund 1 is available at https://againvest.varia.com/.
Virgo provides the leading artificial intelligence cloud video capture, management and analytics platform for endoscopic medicine. Academic, integrative and private practice healthcare providers use the Virgo platform to advance patient care through video-based research and training initiatives. Since launch, Virgo has helped physicians capture over 400,000 endoscopy procedures using industry leading HIPAA, HITRUST and SOC 2 compliant providers. Virgo also supports integration with all major electronic health record systems. In 2021, Virgo launched a set of tools called VirgoTrials that help pharmaceutical trial sponsors and their participating trial sites accelerate patient recruitment and shorten the overall enrollment period for trials. For more information, visit www.virgosvs.com.
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute manages the practice, research and educational programs of the organization. For more information, visit www.gastro.org.
The AGA Center for GI Innovation and Technology supports innovation and the development of new technology in gastroenterology, hepatology, nutrition and obesity by guiding medical device and therapeutic innovators through the technology development and adoption process.
About Varia Ventures
Varia Ventures is a next-generation venture capital platform for professional organizations interested in building wealth for themselves and their members by investing in a portfolio of well-run, emerging companies originating from their organizations. Varia’s platform blends insights from key opinion leaders, strategic partners and industry experts with its “end-to-end” technology solution designed to support early-stage companies while providing compelling investment opportunities to its investors. For more information, visit variaventures.com.
Newswire.com Press Service
Original Source: AI-Fueled Endoscopy Capture and Clinical Trials Platform, Virgo Surgical Video Solutions, Receives Support From American Gastroenterological Association Venture Fund